Do Innovators In Science Deserve Research Support As A Royalty?

In a recent retrospective, I mused about the similarity in role and function between inventors in the world of commerce and innovators in the realm of scientific research (J.B. Fenn, Annual Review of Physical Chemistry, 46:1-41, 1996). Noting that inventors can apply for a patent, which provides them with exclusive use of the invention for a limited time, I suggested that innovators in research should also receive something more palpable than references to their work in the publications of the

Written byJohn Fenn
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In a recent retrospective, I mused about the similarity in role and function between inventors in the world of commerce and innovators in the realm of scientific research (J.B. Fenn, Annual Review of Physical Chemistry, 46:1-41, 1996). Noting that inventors can apply for a patent, which provides them with exclusive use of the invention for a limited time, I suggested that innovators in research should also receive something more palpable than references to their work in the publications of their competitors, a sort of noblesse oblige that is not always faithfully fulfilled. I also suggested that the philosophy of the patent system might provide a useful basis for rewarding scientific innovation. These general ideas apparently resonated with others of my ilk and thus led to this commentary.

The first patent of record was issued by the Republic of Florence in 1421. Since then, the custom of awarding patents for discoveries ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies